Dystrophic epidermolysis bullosa: pathogenesis and clinical features

Dermatol Clin. 2010 Jan;28(1):107-14. doi: 10.1016/j.det.2009.10.020.


Dystrophic epidermolysis bullosa (DEB) is relatively well understood. Potential therapies are in development. This article describes the pathogenesis and clinical features of DEB. It also describes therapeutic options and the future of molecular therapies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dermis / pathology*
  • Epidermis / pathology*
  • Epidermolysis Bullosa Dystrophica / etiology*
  • Epidermolysis Bullosa Dystrophica / pathology*
  • Epidermolysis Bullosa Dystrophica / therapy
  • Humans